Is MLCLI.PA stock a buy after the close at €1.90?

MLCLI.PA stock shows a potential short-term bounce but fundamentals are weak. Meyka AI grades it C+ and suggests HOLD. Consider small positions and strict stops because liquidity and valuation risks can limit upside.

What upside does Meyka AI forecast for MLCLI.PA stock?

Meyka AI's forecast model projects a yearly price of €2.02 for MLCLI.PA stock, implying about **6.20%** upside versus the current **€1.90**. Forecasts are model-based projections and not guarantees.

What are the main risks for MLCLI.PA stock in an oversold bounce trade?

Key risks include a very low current ratio (**0.02**), negative net income per share (**-0.50**), thin average volume (**4.00** shares), and a rich price-to-sales (**18.70**). Any bounce can be short-lived without fundamental improvement.

Where can I find more news and real-time quotes for MLCLI.PA stock?

For market news and comparisons consult established news feeds such as [Investing.com](https://www.investing.com) and the issuer website. Meyka AI also provides a live stock page for MLCLI.PA with analytics and alerts.

EU Stocks

MLCLI.PA stock at EUR 1.90 on 06 Jan 2026: market closed, oversold bounce watch

ByDanny Kontos January 7, 2026January 7, 2026

MLCLI.PA stock closed at €1.90 on EURONEXT on 06 Jan 2026, with 10 shares traded and a relative volume of 2.50. The price sits at the year low of €1.90 against a year high of €2.06, setting up an oversold bounce scenario. Short trading volume and tight ranges have left the stock technically stretched, while fundamentals show liquidity constraints and a high price-to-sales ratio. We examine technical triggers, valuation risks, and Meyka AI forecasts for a balanced watchlist entry.